Common

Top Private School in Melbourne Says 'Cognitive Flexibility' Key to Learning and Creativity

Retrieved on: 
Wednesday, August 18, 2021
Problem solving, Creativity, Student, IQ, Knowledge, Thought, Science, Learning, Memory, Common, COVID-19, Goal, Technology, News, Environment, Management, Tutoring

Regarded as one of the best private schools Melbourne wide, Haileybury says flexible thinking is the key to creativity and supports academic work and skills such as problem solving.

Key Points: 
  • Regarded as one of the best private schools Melbourne wide, Haileybury says flexible thinking is the key to creativity and supports academic work and skills such as problem solving.
  • According to Haileybury , cognitive flexibility is a skill which enables people to switch between different concepts or adapt behaviour to achieve goals in a rational way.
  • Deemed the best private school Melbourne wide, Haileybury says the good news is that students can be trained in cognitive flexibility.
  • As the top private school Melbourne wide, Haileybury says teaching students cognitive flexibility is essential to help them maximise their potential and also for society to flourish in the future.

Manulife Investment Management further strengthens emerging markets capabilities

Retrieved on: 
Wednesday, August 18, 2021
CAD, Growth, HSBC, Deloitte, CFA, Manulife, Female, Chartered accountant, EMEA, Citywire, ESG, US, Pedigree, Schroders, MSCI, Jupiter Fund Management, Common, Retirement, Aviva Investors, Security (finance), Financial adviser, Bank

Appoints Bryony Deuchars, CFA, senior investment analyst and Talib Saifee, portfolio manager, to its emerging markets equity strategies

Key Points: 
  • Appoints Bryony Deuchars, CFA, senior investment analyst and Talib Saifee, portfolio manager, to its emerging markets equity strategies
    BOSTON and LONDON, Aug. 18, 2021 /CNW/ -Manulife Investment Management today announced the appointment of Bryony Deuchars, CFA, senior investment analyst, to its emerging markets equity strategies effective 16 August 2021.
  • Across emerging markets equity and debt, including Asia ex-Japan, Manulife Investment Management oversees more than $90 billion in assets under management for investors.1
    "We view our capabilities in emerging markets, both debt and equity, as one of our competitive advantages in the marketplace," said Christopher P. Conkey, CFA, global head of public markets at Manulife Investment Management.
  • Having spent the majority of her professional career focused on emerging markets, I am confident that she will make an immediate contribution to our team," said Kathryn Langridge, senior portfolio manager, emerging markets equity, Manulife Investment Management.
  • The Manulife Investment Management emerging markets equity team was formed in 2014 when Kathryn Langridge and Philip Ehrmann joined the firm from Jupiter Asset Management.

Manulife Investment Management further strengthens emerging markets capabilities

Retrieved on: 
Wednesday, August 18, 2021
CAD, Growth, HSBC, Deloitte, CFA, Manulife, Female, Chartered accountant, Multimedia, EMEA, Citywire, ESG, US, Pedigree, Schroders, MSCI, Jupiter Fund Management, Common, Retirement, Aviva Investors, Security (finance), Financial adviser, Bank

Appoints Bryony Deuchars, CFA, senior investment analyst and Talib Saifee, portfolio manager, to its emerging markets equity strategies

Key Points: 
  • Appoints Bryony Deuchars, CFA, senior investment analyst and Talib Saifee, portfolio manager, to its emerging markets equity strategies
    BOSTON and LONDON, Aug. 18, 2021 /PRNewswire/ -Manulife Investment Management today announced the appointment of Bryony Deuchars, CFA, senior investment analyst, to its emerging markets equity strategies effective 16 August 2021.
  • Across emerging markets equity and debt, including Asia ex-Japan, Manulife Investment Management oversees more than $90 billion in assets under management for investors.1
    "We view our capabilities in emerging markets, both debt and equity, as one of our competitive advantages in the marketplace," said Christopher P. Conkey, CFA, global head of public markets at Manulife Investment Management.
  • Having spent the majority of her professional career focused on emerging markets, I am confident that she will make an immediate contribution to our team," said Kathryn Langridge, senior portfolio manager, emerging markets equity, Manulife Investment Management.
  • The Manulife Investment Management emerging markets equity team was formed in 2014 when Kathryn Langridge and Philip Ehrmann joined the firm from Jupiter Asset Management.

FDA Clears BrainsWay Deep TMS™ System for Decreasing Anxiety Symptoms in Depressed Patients

Retrieved on: 
Wednesday, August 18, 2021
Company, Standard of care, Private Securities Litigation Reform Act, Legislation, Nervous, Heart rate, U.S. Securities and Exchange Commission, Brainsway, GLOBE, TMS, Anxiety, Panic, Knowledge, Thought, Insurance, Tic disorder, Food, Psychiatry, Health, Insomnia, Lists of diseases, Addiction, Awareness, Deep, Uncertainty, Review, NASDAQ, Adult, Perspiration, Failure, News, Patient, Tremor, Solution, Depression, Comorbidity, Genta (company), FDA, Transcranial magnetic stimulation, RCT, Annual report, COVID-19, Common, Technology, TASE, Regulation of tobacco by the U.S. Food and Drug Administration, MD, Pharmaceutical industry

Data from 573 patients who had undergone Deep TMS treatment in 11 studies, including both randomized controlled trials (RCT) and open-label studies, was submitted by BrainsWay in support of its application to the FDA.

Key Points: 
  • Data from 573 patients who had undergone Deep TMS treatment in 11 studies, including both randomized controlled trials (RCT) and open-label studies, was submitted by BrainsWay in support of its application to the FDA.
  • The data demonstrated a treatment effect that was consistent, robust, and clinically meaningful for decreasing anxiety symptoms in adult patients suffering from major depressive disorder.
  • An analysis of the BrainsWay data found favorable outcomes with Deep TMS when compared to sham or medication as standard of care.
  • The expanded FDA labeling now allows BrainsWay to market its Deep TMS System for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from major depressive disorder and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.

Guardian Capital Announces August 2021 Distributions for Guardian Capital ETFs

GCG, Communication, Insurance, Guardian Capital Group, ETF, Investment, Prospectus, Capital, TSX, Foundation, Toronto Stock Exchange, Common, Bank, Financial adviser

Guardian Capital LP is the manager and portfolio manager of the Guardian Capital Funds and Guardian Capital ETFs, with capabilities that span a range of asset classes, geographic regions and specialty mandates.

Key Points: 
  • Guardian Capital LP is the manager and portfolio manager of the Guardian Capital Funds and Guardian Capital ETFs, with capabilities that span a range of asset classes, geographic regions and specialty mandates.
  • Guardian Capital LP is a wholly owned subsidiary of Guardian Capital Group Limited and the successor to its original investment management business, which was founded in 1962.
  • Guardian Capital Group Limited (Guardian) is a diversified, global financial services company operating in two main business segments: Asset Management and Wealth Management.
  • As at June 30, 2021, Guardian had C$52 billion of assets under management and C$30 billion of assets under administration.

Blackwells Capital Issues Presentation on Monmouth Equity Commonwealth Merger Highlighting That EQC is Now Offering Even Less Consideration for a More Valuable Monmouth

Retrieved on: 
Tuesday, August 17, 2021
LLC, UPON, NO, WHEN, GLOBE, Insurance, Common stock, MNR, Participation, NEW, NYSE, Investment, Board, THE, Common, EQC, Technology, Blackwells, Security (finance), Auction

NEW YORK, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Blackwells Capital, LLC today announced that it has issued a supplemental investor presentation following the announcement of the amended proposed merger between Monmouth Real Estate Investment Corporation’s (NYSE: MNR) ("Monmouth" or the "Company") and Equity Commonwealth (NYSE: EQC) (“EQC”).

Key Points: 
  • Among other key details in the presentation, Blackwells highlights:
    EQC offer of $19.00 on August 16th is below its original offer of $19.40 on May 4th.
  • Industrial cap rates declined approximately 30bps since EQCs original offer on May 4th, which implies EQCs original offer should have been revised up to $21.63 per Monmouth share.
  • The Monmouth Board somehow managed to re-negotiate a worse deal for shareholders.
  • Accordingly, Blackwells encourages shareholders to review all available information and vote AGAINST the merger with EQC, including its detailed presentation of August 6, 2021, available at MaximizeMNR.com/presentations .

Global Acrylic Pressure Sensitive Adhesives Market (2021 to 2026) - Growth, Trends, COVID-19 Impact and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 17, 2021
Chemicals, Plastics, Manufacturing, Ageing, Transport, Henkel, Growth, Life, Chemical substance, PSA, Shear strength, PSAS, Temperature, Avery Dennison, FMCG, Commercial, School, Adhesive, Common, Acrylic

Common examples of acrylic PSA tapes are electrical tapes, duct tapes, masking tapes, surgical tapes, and box-sealing tapes, among others.

Key Points: 
  • Common examples of acrylic PSA tapes are electrical tapes, duct tapes, masking tapes, surgical tapes, and box-sealing tapes, among others.
  • With over 40% of the global demand, Asia-Pacific is the most promising market for acrylic pressure-sensitive adhesives, which is likely to dominate the market in the near future.
  • The growing packaging and automotive industries are driving the market for acrylic pressure-sensitive adhesives in this region.
  • The huge growth of Asia-Pacific is quite instrumental in the expansion of the acrylic pressure-sensitive adhesives market.

SweetSpot Labs Launches Microbiome Balancing Cleanser

Retrieved on: 
Tuesday, August 17, 2021
General manager, MD, Fungal folliculitis, Sulfate, Skin, Ceramide, Fungus, Ulta Beauty, Health, Folliculitis, Organic acid, FACOG, Multimedia, Paraben, Patient, Ester, Woman, Common, View, Cosmetics

NEW YORK, Aug. 17, 2021 /PRNewswire/ --SweetSpot Labs, a leader in vulvar skincare who has been bringing intimate skin health to light since 2003, launches its new Microbiome Balancing Creamy Full Body Cleanser to help women who struggle with common, but often unaddressed, vulvar skin imbalances.

Key Points: 
  • NEW YORK, Aug. 17, 2021 /PRNewswire/ --SweetSpot Labs, a leader in vulvar skincare who has been bringing intimate skin health to light since 2003, launches its new Microbiome Balancing Creamy Full Body Cleanser to help women who struggle with common, but often unaddressed, vulvar skin imbalances.
  • "SweetSpot Labs' new Microbiome Balancing Cleanser is packed with clean ingredients and formulated without known Malassezia triggers, leading to balanced and more comfortable vulvar skin."
  • Julie Chamberlain, General Manager of SweetSpot Labs says, "The launch of Microbiome Balancing Cleanser is an exciting new chapter in SweetSpot Labs long-standing commitment to the health of intimate skin.
  • Like all SweetSpot Labs products, Microbiome Balancing Wash is gynecologist tested and approved on actual vulvas.

Anticancer Agent "Tazverik Tablets 200mg" (Tazemetostat Hydrobromide) Launched in Japan for EZH2 Gene Mutation-Positive Follicular Lymphoma

Retrieved on: 
Monday, August 16, 2021
Dysgeusia, Common, Phosphorylation, S-Adenosyl methionine, Cell division, Refractory, Lymphoma, Gene, Incidence, Eisai, Continuity, Science, Efficiency, Molecular Cancer Research, Research, DNA, Methylation, Nature Genetics, Genetics, Ageing, American Association for Cancer Research, Therapy, Diffuse large B-cell lymphoma, ORR, Automation, Carcinogenesis, Acetylation, Mutation, Review, Follicular lymphoma, EZH2, Advanced manufacturing, Safety, Adult, Blood, Patient, Lymphocytopenia, Relapse, Neoplasm, FDA, Veni, vidi, vici, Histone, Technology, Gene expression, Vaccine, Fine chemical, Pharmaceutical industry, Wood drying

This agent selectively inhibits EZH2 in a competitive matter with S-adenosylmethionine (a methyl group donor) to suppress methylation of H3K27.

Key Points: 
  • This agent selectively inhibits EZH2 in a competitive matter with S-adenosylmethionine (a methyl group donor) to suppress methylation of H3K27.
  • Eisai was one of the first to adopt Continuous Manufacturing system (CTS-MiGRA) and applied this technology to the production of this agent.
  • Study 206 enrolled patients with EZH2 gene mutation-positive, primarily follicular lymphoma, who had relapsed or were refractory.
  • Somatic mutation of EZH2 (Y641) in Follicular and Diffuse Large B-cell Lymphomas of Germinal Center Origin.

Vislink Reports Second Quarter 2021 Financial Results

Retrieved on: 
Monday, August 16, 2021
CFO, Income, Sport, ATSC, EBITDA, APT, U.S. Department of Defense Strategy for Operating in Cyberspace, Nasdaq, Olympic Games, History, UEFA Euro 2020, CEO, Company, Intelligence, Private Securities Litigation Reform Act, DVE, COVID-19, Significant figures, Russell, Department, Alabama Public Television, GLOBE, IP, Department of Defense Architecture Framework, GAAP, SEC, Net, Acquisition, Webcast, Growth, Leadership, ISR, Budget, Knowledge, Collection, Depreciation, Common, Solution, Law enforcement, Animal, Video game, Risk management

Hackettstown, NJ, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Vislink (“the “Company”) (Nasdaq: VISL), a global technology in the capture, delivery and management of high quality, live video and associated data in the media & entertainment, law enforcement and defense markets, reported financial results for the quarter ended June 30, 2021, 2021. Company management will host a live webcast on Tuesday, August 17, 2021 at approximately 10:00 a.m. ET to review the Company’s financial and operating results and provide a general business update (see webcast details below).

Key Points: 
  • Ended the second quarter of 2021 with $55.5 million in cash and cash equivalents, compared to $60 million at the end of the first quarter of 2021.
  • Gross margins were 52.8% of revenue in the second quarter of 2021, compared to 46% in the first quarter of 2021.
  • Net loss attributable to common shareholders was $834,000, or $(0.02) per share in the second quarter of 2021 compared to a net loss of $2.7 million, or $(0.07) per share in the first quarter of 2021 and a net loss of $778,000, or $(0.05) per share in the second quarter of 2020.
  • We are very pleased to report revenues in the second quarter that were over 85% higher than the amount recorded in the first quarter of 2021, said Mickey Miller, CEO of Vislink.